explore -WSS

explore

author：knowledge 2025-10-01 23:58:04 - browse：2

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： STAT Readout Newsletter: Today's biggest biotech updates

WSS

Senate committee scrutinizes Medicare Advantage brokers

The EU Joint Clinical Assessment needs to live up to its promise

Elon Musk announces 'temporary limits' for reading Twitter posts

Some in Scotland's Orkney Islands want to return to Norway after 550 years

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Beam Therapeutics to lay off 20% of its staff, re

Wikipedia

explore

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Supreme Court strikes down use of affirmative action

Senate committee scrutinizes Medicare Advantage brokers

Virginia high school admissions case could be legal follow

STAT Summit: Biotech founders on deal

In age of alternative facts, a scholarly course on calling out crap

EU climate chief is concerned over the expansion of the coal industry in China

As demand for Covid shots wanes, Moderna seeks its next success

Pharmacists can make shortage drugs, but at what cost?

knowledge

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Lawmakers consider Medicare pay reforms for doctors

4 dead, 2 in stable condition in Philadelphia shooting: Police

Solve the antibiotic resistance crisis with preventive drugs

Pharmacists can make shortage drugs, but at what cost?

Some in Scotland's Orkney Islands want to return to Norway after 550 years

focus

focus

hotspot

Wikipedia